Wellington Management Group

Wellington Management Group Portfolio holdings

AUM $571B
1-Year Est. Return 25.59%
 

Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.

This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+25.59%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$571B
AUM Growth
-$592M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,066
New
Increased
Reduced
Closed

Top Buys

1 +$1.76B
2 +$1.35B
3 +$1.19B
4
HBAN icon
Huntington Bancshares
HBAN
+$1.12B
5
DASH icon
DoorDash
DASH
+$1.1B

Top Sells

1 +$2.38B
2 +$1.79B
3 +$1.73B
4
MSFT icon
Microsoft
MSFT
+$1.36B
5
META icon
Meta Platforms (Facebook)
META
+$1.28B

Sector Composition

1 Technology 25.33%
2 Healthcare 17.16%
3 Financials 15.22%
4 Consumer Discretionary 9.7%
5 Industrials 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAGS icon
1626
PagSeguro Digital
PAGS
$3.09B
$974K ﹤0.01%
101,055
-267,638
AVXL icon
1627
Anavex Life Sciences
AVXL
$413M
$969K ﹤0.01%
272,231
-16,582
ALT icon
1628
Altimmune
ALT
$559M
$929K ﹤0.01%
257,271
-7,531
OGN icon
1629
Organon & Co
OGN
$1.88B
$928K ﹤0.01%
129,375
-5,053
ALDX icon
1630
Aldeyra Therapeutics
ALDX
$331M
$926K ﹤0.01%
178,851
-10,970
DYN icon
1631
Dyne Therapeutics
DYN
$2.67B
$921K ﹤0.01%
47,096
+5,181
DOC icon
1632
Healthpeak Properties
DOC
$12.2B
$909K ﹤0.01%
56,544
-82,625
OCUL icon
1633
Ocular Therapeutix
OCUL
$2.09B
$902K ﹤0.01%
74,317
+12,753
DNLI icon
1634
Denali Therapeutics
DNLI
$3.34B
$901K ﹤0.01%
54,543
-4,691
OPBK icon
1635
OP Bancorp
OPBK
$205M
$892K ﹤0.01%
63,168
-7,131
HAFN icon
1636
Hafnia
HAFN
$3.71B
$890K ﹤0.01%
166,348
+46,359
ICL icon
1637
ICL Group
ICL
$6.35B
$880K ﹤0.01%
153,297
+3,175
LENZ
1638
LENZ Therapeutics
LENZ
$423M
$870K ﹤0.01%
54,402
-6,919
AVIR icon
1639
Atea Pharmaceuticals
AVIR
$366M
$867K ﹤0.01%
242,840
-19,935
PRME icon
1640
Prime Medicine
PRME
$791M
$861K ﹤0.01%
248,227
+42,902
AUPH icon
1641
Aurinia Pharmaceuticals
AUPH
$1.84B
$857K ﹤0.01%
53,721
+2,421
JKHY icon
1642
Jack Henry & Associates
JKHY
$11.6B
$857K ﹤0.01%
4,695
+177
URI icon
1643
United Rentals
URI
$54.1B
$845K ﹤0.01%
1,044
-641
LTM
1644
LATAM Airlines Group S.A.
LTM
$16.7B
$844K ﹤0.01%
+15,622
DHI icon
1645
D.R. Horton
DHI
$46.1B
$841K ﹤0.01%
5,837
-2,688
DOCS icon
1646
Doximity
DOCS
$4.64B
$840K ﹤0.01%
18,979
+2,224
AFL icon
1647
Aflac
AFL
$59.1B
$835K ﹤0.01%
7,569
-296
ARTV
1648
Artiva Biotherapeutics
ARTV
$134M
$833K ﹤0.01%
194,108
LXEO icon
1649
Lexeo Therapeutics
LXEO
$504M
$826K ﹤0.01%
+83,230
DMAC icon
1650
DiaMedica Therapeutics
DMAC
$429M
$825K ﹤0.01%
+103,704